Skip to main content

Table 3 Patients’ characteristics in surgical and non-surgical groups

From: Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer

Item Surgical resection No surgical resection p value
Median age 50.5 (IQR 41–57) 54 (IQR 43–59) 0.8
Males % 9 (69.3%) 18 (47.2%) 0.2
Median performance status 1 (IQR 0.5–1) 1 (IQR 1–2) 0.3
% right-sided primary 3 (23.1%) 8 (21.1%) 0.8
Median number metastatic site 1 (IQR 1–2) 2 (IQR 1–3) 0.09
% mutant KRAS 7 (53.8%) 13 (34.2%) 0.3
% best response 11 (84.6%) 18 (56.2%) 0.3
  1. IQR interquartile range